RU2001101921A - QUANTITATIVE ANALYSIS FOR IDENTIFYING THE PRESENCE OF UNFULFORABLE EGGS - Google Patents

QUANTITATIVE ANALYSIS FOR IDENTIFYING THE PRESENCE OF UNFULFORABLE EGGS

Info

Publication number
RU2001101921A
RU2001101921A RU2001101921/14A RU2001101921A RU2001101921A RU 2001101921 A RU2001101921 A RU 2001101921A RU 2001101921/14 A RU2001101921/14 A RU 2001101921/14A RU 2001101921 A RU2001101921 A RU 2001101921A RU 2001101921 A RU2001101921 A RU 2001101921A
Authority
RU
Russia
Prior art keywords
quantitative analysis
mammal
paragraphs
amount
sample
Prior art date
Application number
RU2001101921/14A
Other languages
Russian (ru)
Other versions
RU2227916C2 (en
Inventor
Свенн ЛИНДЕНБЕРГ
Анне Лис МИККЕЛЬСЕН
Original Assignee
Меди-Культ А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK199900885A external-priority patent/DK199900885A/en
Application filed by Меди-Культ А/С filed Critical Меди-Культ А/С
Publication of RU2001101921A publication Critical patent/RU2001101921A/en
Application granted granted Critical
Publication of RU2227916C2 publication Critical patent/RU2227916C2/en

Links

Claims (15)

1. Количественный анализ на присутствие или количество вещества в образце из секретов организма, мокроты, крови, мочи или маточного секрета у млекопитающего, применяемый для прогноза присутствия у млекопитающего неоплодотворяемых яйцеклеток, способных к созреванию in vitro и последующему оплодотворению.1. A quantitative analysis for the presence or quantity of a substance in a sample from body secrets, sputum, blood, urine or uterine secretions in a mammal, used to predict the presence of unfertilized eggs in a mammal that can mature in vitro and subsequently fertilize. 2. Количественный анализ по п. 1, в котором прогноз включает в себя определение, когда у млекопитающего присутствуют неоплодотворяемые яйцеклетки, способные к созреванию in vitro и последующему оплодотворению, дроблению, имплантации и беременности. 2. The quantitative analysis according to claim 1, wherein the prognosis includes determining when a mammal has infertile eggs capable of in vitro maturation and subsequent fertilization, crushing, implantation and pregnancy. 3. Количественный анализ по п. 1 или 2, в котором вещество представляет собой гормон, мелкий пептидный гормон, пептидный гормон, липид, нуклеиновую кислоту, внутри- или межклеточный посредник или фермент. 3. The quantitative analysis of claim 1 or 2, wherein the substance is a hormone, a small peptide hormone, a peptide hormone, a lipid, a nucleic acid, an intracellular or intercellular mediator, or an enzyme. 4. Количественный анализ по любому из пп. 1-3, в котором образец представляет собой образец крови. 4. Quantitative analysis according to any one of paragraphs. 1-3, in which the sample is a blood sample. 5. Количественный анализ по любому из предшествующих пунктов, в котором млекопитающее представляет собой примата, такого как человек. 5. Quantitative analysis according to any one of the preceding paragraphs, in which the mammal is a primate, such as a human. 6. Количественный анализ по любому из предшествующих пунктов, в котором присутствие или количество определяют с помощью иммуноанализа и/или полимеразной цепной реакции. 6. Quantitative analysis according to any one of the preceding paragraphs, in which the presence or amount is determined by immunoassay and / or polymerase chain reaction. 7. Количественный анализ по любому из предшествующих пунктов, в котором определяют присутствие или количество ингибина А. 7. Quantitative analysis according to any one of the preceding paragraphs, which determine the presence or amount of inhibin A. 8. Количественный анализ по любому из предшествующих пунктов, в котором определяют присутствие или количество эстрадиола. 8. Quantitative analysis according to any one of the preceding paragraphs, which determine the presence or amount of estradiol. 9. Способ определения времени присутствия у млекопитающего неоплодотворяемых яйцеклеток, способных к созреванию in vitro и последующему оплодотворению, включающий в себя количественный анализ на присутствие или количество вещества в образце секрета организма, мокроты, крови, мочи или маточного секрета у млекопитающего. 9. A method for determining the time of presence in a mammal of unfertilized eggs capable of in vitro maturation and subsequent fertilization, comprising a quantitative analysis for the presence or quantity of a substance in a sample of body secretion, sputum, blood, urine or uterine secretion in a mammal. 10. Способ по п. 9, в котором вещество представляет собой гормон, мелкий пептидный гормон, пептидный гормон, липид, нуклеиновую кислоту, внутри- или межклеточный посредник или фермент. 10. The method of claim 9, wherein the substance is a hormone, a small peptide hormone, a peptide hormone, lipid, nucleic acid, an intracellular or intercellular mediator, or an enzyme. 11. Способ по п. 9 или 10, в котором образец представляет собой образец крови. 11. The method of claim 9 or 10, wherein the sample is a blood sample. 12. Способ по любому из пп. 9-11, в котором млекопитающее представляет собой примата, такого как человек. 12. The method according to any one of paragraphs. 9-11, in which the mammal is a primate, such as a human. 13. Способ по любому из пп. 9-12, в котором время определяют на 3-й день менструального цикла по количеству ингибина А менее, чем 10 пкг/мл. 13. The method according to any one of paragraphs. 9-12, in which time is determined on the 3rd day of the menstrual cycle by the amount of inhibin A less than 10 pcg / ml. 14. Способ по любому из пп. 9-13, в котором время определяют по увеличению количества ингибина А с 3-го дня менструального цикла до дня аспирации более чем на 80%. 14. The method according to any one of paragraphs. 9-13, in which time is determined by the increase in the amount of inhibin A from the 3rd day of the menstrual cycle to the day of aspiration by more than 80%. 15. Способ по любому из пп. 9-14, в котором время определяют по увеличению количества эстрадиола с 3-го дня менструального цикла до дня аспирации более чем на 87%. 15. The method according to any one of paragraphs. 9-14, in which time is determined by an increase in the amount of estradiol from the 3rd day of the menstrual cycle to the day of aspiration by more than 87%.
RU2001101921/15A 1998-06-22 1999-06-22 Quantitative analysis method for detecting non-impregnated ovocytes RU2227916C2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9011598P 1998-06-22 1998-06-22
US60/090,115 1998-06-22
DK199900885A DK199900885A (en) 1998-06-22 Procedure for assigning any amount to a given credit card account
DKPA199800885 1998-06-22

Publications (2)

Publication Number Publication Date
RU2001101921A true RU2001101921A (en) 2002-11-10
RU2227916C2 RU2227916C2 (en) 2004-04-27

Family

ID=26064838

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001101921/15A RU2227916C2 (en) 1998-06-22 1999-06-22 Quantitative analysis method for detecting non-impregnated ovocytes

Country Status (23)

Country Link
US (2) US20020115211A1 (en)
EP (2) EP1090300B1 (en)
JP (1) JP2002519640A (en)
CN (2) CN1161615C (en)
AT (1) ATE407363T1 (en)
AU (2) AU4360599A (en)
BR (1) BR9911470A (en)
CA (2) CA2335793A1 (en)
DE (1) DE69939468D1 (en)
EE (1) EE200000763A (en)
ES (1) ES2313785T3 (en)
HR (1) HRP20000888A2 (en)
HU (1) HUP0103392A2 (en)
ID (1) ID27197A (en)
IL (2) IL140394A0 (en)
IS (1) IS5768A (en)
NO (2) NO20006519L (en)
NZ (1) NZ509451A (en)
PL (1) PL345318A1 (en)
RU (1) RU2227916C2 (en)
SK (1) SK19152000A3 (en)
TR (1) TR200003830T2 (en)
WO (2) WO1999067644A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005518823A (en) * 2002-03-08 2005-06-30 マクギル・ユニバーシテイ In vitro maturation of immature human oocytes
JP2005529609A (en) * 2002-06-17 2005-10-06 ケベンハウンス・アムツ・シゲフス・ハーレウ In vitro fertilization
PT2325201T (en) * 2003-11-26 2017-01-09 Merck Serono Sa Use of il-6-type cytokines for maturation of oocytes
US20070020755A1 (en) * 2005-07-07 2007-01-25 Teresa Woodruff Stage specific follicle maturation systems
CN103275930B (en) * 2013-06-20 2014-07-09 江苏皓康生物医药科技有限公司 Oocyte in-vitro maturity nutrient solution and preparation method thereof
EP3155092B1 (en) * 2014-06-10 2024-02-28 polybiocept GmbH Culture medium for cellular immunotherapy
BR112018068474B1 (en) * 2016-02-24 2024-01-30 Universitá Degli Studi Di Milano, Unimi FOLLICULAR SYSTEM FOR IN VITRO OOCYTE MATURATION AND KIT
CN110628705A (en) * 2019-10-22 2019-12-31 山东畜牧兽医职业学院 Donkey embryo flushing fluid and application method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614715A (en) * 1982-05-14 1986-09-30 The Board Of Trustees Of The University Of Illinois Predictive test for impending ovulation in mammals
RU2013989C1 (en) * 1991-08-13 1994-06-15 Борис Васильевич Леонов Method for determining ovulation
GB9217866D0 (en) * 1992-08-21 1992-10-07 Unilever Plc Monitoring method
CA2176248A1 (en) * 1993-12-16 1995-06-22 Steven C. March Methods and means for determining the female fertile period
GB9410345D0 (en) * 1994-05-24 1994-07-13 Univ Oxford Brookes Method of genetic testing
GB9603326D0 (en) * 1996-02-16 1996-04-17 Royal Free Hosp School Med Predictive assay
ATE213333T1 (en) * 1996-09-27 2002-02-15 Unilever Nv MONITORING PROCEDURES
GB9625175D0 (en) * 1996-12-04 1997-01-22 Medi Cult As Serum-free cell culture media

Similar Documents

Publication Publication Date Title
US5635366A (en) Predictive assay for the outcome of IVF
Ellison Advances in human reproductive ecology
Rajabi et al. Elevated tissue levels of collagenase during dilation of uterine cervix in human parturition
Dawuda et al. Effect of timing of urea feeding on the yield and quality of embryos in lactating dairy cows
Beier et al. Specific secretory protein of the female genital tract
Trummer et al. Thyroid hormones and thyroid antibodies in infertile males
RU2001101921A (en) QUANTITATIVE ANALYSIS FOR IDENTIFYING THE PRESENCE OF UNFULFORABLE EGGS
KR20120066597A (en) A method of diagnosing a menstrual activation using saliva
US4614715A (en) Predictive test for impending ovulation in mammals
RU2227916C2 (en) Quantitative analysis method for detecting non-impregnated ovocytes
AU4502393A (en) Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
EP0544805B1 (en) Hormone detection methods
Batra et al. Nuclear estrogen receptors in human uterine arteries
Brandenberger et al. CA-125 concentrations in the serum and pregnancy outcome in IVF cycles
Eggert-Kruse et al. Herpes simplex virus infection of the uterine cervix—relationship with a cervical factor?
Abramovici et al. Pregnancies following the interval double-transfer technique in an in vitro fertilization-embryo transfer program
Wąsowska et al. Apoptotic cell death in the porcine endometrium during the oestrous cycle
Umapathysivam et al. Effects of contraceptive agents on the biochemical and protein composition of human endometrium
KR20080072353A (en) Uses of mmp-9 activities present in blood
Aitken The protein content of mouse uterine flushings during pseudopregnancy
Jimena et al. Distribution of free amino acids in human preovulatory follicles
Martinez et al. CA-125 levels in cervical mucus during the menstrual cycle
Mervat et al. Evaluation of corpora lutea effect on ovarian morphometry, follicular population and biochemical profile in follicular fluid and blood of slaughtered cows
Jones Analysis of Body Fluids in Sexual Assault Cases
MacLaughlin et al. Analysis of proteins secreted by the human endometrium in vivo and in vitro